Table 3.
Reasons for Ceasing Active Surveillance and Electing Treatment (n=43)*
Number (%) | |
---|---|
Gleason ≥ 7 on surveillance biopsy | 15 (35%) |
Surveillance biopsy with > 3 cores or >50% in a single core | 7 (16%) |
Change in patient preference | 6 (14%) |
Rising PSA without worsening biopsy features | 2 (5%) |
MRI findings | 2 (5%) |
Voiding symptoms | 1 (2%) |
Bone metastases | 1 (2%) |
Upstaging via digital rectal examination | 1 (2%) |
Unknown | 12 (28%) |
Greater than 100% as some patients had multiple reasons